Matthew H. Herynk, Ph.D.

Affiliations: 
2002 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Cell Biology, Oncology
Google:
"Matthew Herynk"

Parents

Sign in to add mentor
Gary Gallick grad student 2002 The University of Texas Graduate School of Biomedical Sciences at Houston
 (Activation of c -Met contributes to growth and metastasis of human colorectal carcinoma.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Patel SA, Herynk MH, Cascone T, et al. (2021) Estrogen promotes resistance to bevacizumab in murine models of non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer
Cascone T, Herynk MH, Xu L, et al. (2011) Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma. The Journal of Clinical Investigation. 121: 1313-28
Barone I, Cui Y, Herynk MH, et al. (2009) Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway. Cancer Research. 69: 4724-32
Herynk MH, Zhang J, Parikh NU, et al. (2007) Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. Journal of Experimental Therapeutics & Oncology. 6: 205-17
Herynk MH, Beyer AR, Cui Y, et al. (2006) Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells. Molecular Cancer Therapeutics. 5: 3023-31
Minard ME, Herynk MH, Collard JG, et al. (2005) The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene. 24: 2568-73
Kim SJ, Johnson M, Koterba K, et al. (2003) Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 5161-70
Herynk MH, Tsan R, Radinsky R, et al. (2003) Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clinical & Experimental Metastasis. 20: 291-300
Herynk MH, Stoeltzing O, Reinmuth N, et al. (2003) Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Research. 63: 2990-6
See more...